AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH

RecruitingNAAges 18 Years - 80 YearsAllXiaolei Chen
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The effectiveness of traditional craniotomy in the treatment of intracerebral hemorrhage remains controversial. Minimally invasive surgery, specially, image-guided hematoma aspiration, proves to be effective and may have some advantages compared with craniotomy. This multicenter randomized controlled trial aims to evaluate and compare the clinical efficacy of two minimally invasive treatment strategies for patients with spontaneous supratentorial intracerebral hemorrhage (ICH) with moderate hematoma volume (20-50 mL): (1) AI-assisted, navigation-guided hematoma aspiration, and (2) targeted pharmacological therapy. This study is designed to address the current lack of prospective comparative evidence between advanced image-guided surgical intervention and medical management in this specific patient population. By focusing on functional recovery, hematoma resolution, and safety outcomes, t

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Confirmed supratentorial hypertensive intracerebral hemorrhage on brain CT scan * Hematoma volume 20-50mL * Patients with with GCS score โ‰ฅ8 * Admitted within 24h of ictus Exclusion Criteria: * Intracerebral hemorrhage caused by tumor, coagulopathy, aneurysm, or arteriovenous malformation * Concurrent head injury or history of head injury * Multiple intracerebral hemorrhage * Known advanced demential or disability before * Severe concomitant diseases that affect life expectancy * With severe intraventricular hemorrhage * Pregnant women
๐Ÿ’Š

What it tests

  • AI-Assisted Navigated Hematoma Aspiration
  • Conservative Treatment
๐Ÿ“

Where

1 site
Chinese PLA General Hospital
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy